erenumab
ItalyDrugs containing this active substance
-
It is used to prevent migraine in adults who, at the start of treatment, experience at least 4 migraine days per month.
Form: solution for injection
Active substance Dosage erenumab - ATC: N02CD01
Manufacturer: NOVARTIS EUROPHARM LIMITED